# Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy

> **NCT02806908** · PHASE2 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Narcolepsy
- Excessive Sleepiness

## Interventions

- **DRUG:** JZP-110
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02806908
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2019-05-19
- **Final completion:** 2019-05-19
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02806908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02806908, "Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02806908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*